Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Front Public Health ; 9: 742332, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34660519

RESUMEN

Objective: To compare the EuroQol-5D-3L (EQ-5D-3L) and the Short Form-6D (SF-6D) utility scores in family caregivers (FCs) of colorectal cancer (CRC) patients. Method: This study was performed on FCs of CRC patients from three primary cancer centers in the capital city of the Heilongjiang province. The participants (FCs) who were enrolled, filled the EQ-5D-3L, along with the SF-6D questionnaire. Two tools were compared for their distribution, discriminant validity, agreement, and convergent validity along with known-groups validity. Result: Two hundred ninety-two FCs of CRC patients were enrolled. The score distribution of the SF-6D along with the EQ-5D-3L were not normal. A ceiling impact was seen in 31.8% of the FCs for EQ-5D-3L; however, none for the SF-6D. Good associations (Spearman's rho = 0.622, p < 0.01) and intraclass correlation coefficient (ICC 0.637 and average ICC 0.778) between the two scores were observed. The EQ-5D-3L yielded higher utility scores in contrast with the SF-6D in the better health subclass. The SF-6D distinguished better between excellent and good health statuses, with better effect size and relative efficiency statistics. Both tools showed good known-groups validity. Conclusion: The utility scores of SF-6D were remarkably lower relative to that of the EQ-5D-3L, but the difference may be clinically insignificant. However, the SF-6D may be superior because of the lack of ceiling impact. SF-6D exhibited a better convergent validity along with discrimination validity of excellent health condition and improved known-groups validity efficiency.


Asunto(s)
Cuidadores , Neoplasias Colorrectales , China/epidemiología , Estudios Transversales , Estado de Salud , Humanos , Psicometría , Calidad de Vida
2.
Materials (Basel) ; 14(16)2021 Aug 07.
Artículo en Inglés | MEDLINE | ID: mdl-34442947

RESUMEN

In this study, the evolution of high-strength HSLA steel microstructure was studied using high-temperature laser confocal microscopy and SEM, TEM, and EPMA techniques. The effect of precipitates on grain boundary migration of austenite during high-temperature heating and the effect of inclusions in undercooled austenite on AF phase transformation were studied. The effect of multiphase microstructure on impact toughness was studied by Gleeble thermal simulation at 550, 600, and 650 °C. The results show that the austenite grain is refined by TiN pinning at high temperatures, and a large number of NbC and VCN are precipitated in ferrite for precipitation strengthening. The (Ti-Mn-O) + (Al + Si + Mn-O) + MnS composite inclusions with smaller sizes have a greater promoting effect on the nucleation of acicular ferrite than single-phase MnS. With a decrease in isothermal temperature, the content of acicular ferrite increases. When the isothermal temperature is 550 °C, an increase in the maximum impact toughness of acicular ferrite with large-angle grain boundary is clearly observable.

3.
Cost Eff Resour Alloc ; 18(1): 55, 2020 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-33292288

RESUMEN

BACKGROUND: Budget impact analyses (BIAs) are used for reimbursement decisions and drug access medical insurance, as a supplement to cost-effectiveness analyses (CEAs). OBJECTIVES: We systematically reviewed BIAs for antitumor drugs of lung cancer to provide reference for high-value drug budget impact analyses and decision making. METHODS: We conducted a literature search on PubMed, EMbase, The Cochrane Library, China National Knowledge Infrastructure and Wanfang Data Knowledge Service Platform from 2010 to 2019. The methodological indicators and result information of the budget impact analyses were extracted and evaluated for quality. RESULTS: A total of 14 studies on the budget impact for antitumor drugs of lung cancer were included, and the overall quality was good. Half of studies were from developed countries. Nine of the studies were designed using the BIA cost calculation model, and two were simulated using the Markov model Monte Carlo model. From all studies, only 14.3% reported model validation. The budget impact results of the same drug in different countries were inconsistent. CONCLUSIONS: Included studies evaluating budget impact analyses for anti-tumor drugs of lung cancer showed variability in the methodological framework for BIAs. The budget impact analyses of high-value drugs need to be more stringent to ensure the accuracy of the parameters, and should provide reliable results based on real data to decision-making departments, which should carefully consider access to lung cancer drugs.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...